Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Severe Hepatic Impairment
Related studies linked through entity extraction aliases.
A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143
- Status
- COMPLETED
- Phase
- PHASE1
Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate Severe Hepatic Impairment on Dacomitinib PK
- Status
- COMPLETED
- Phase
- PHASE1
Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects
- Status
- TERMINATED
- Phase
- PHASE4
PK Study in Subjects With Severe Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
- Status
- COMPLETED
- Phase
- PHASE1